RITOMUNE TABLET 60'S

RITOMUNE TABLET 60'S inhibits the HIV protease enzyme, which is necessary for the virus to replicate. By blocking this enzyme, it helps reduce viral replication and control the spread of the virus in the body.

RITOMUNE TABLET 60'S is a protease inhibitor that primarily functions by inhibiting the activity of the HIV protease enzyme. HIV protease plays a crucial role in the life cycle of the virus, facilitating the cleavage of viral polyproteins into individual functional proteins required for viral maturation and infectivity. By inhibiting this enzyme, RITOMUNE TABLET 60'S disrupts the cleavage process, leading to the production of immature, non-infectious viral particles. Additionally, RITOMUNE TABLET 60'S has the unique property of inhibiting certain enzymes in the liver responsible for the breakdown of other protease inhibitors. This action increases the blood levels and half-life of co-administered protease inhibitors, enhancing their effectiveness and reducing the frequency of dosing. RITOMUNE TABLET 60'S also has some inhibitory activity against cytochrome P450 enzymes, which further contributes to its drug-drug interaction potential. Overall, the combination of these mechanisms helps to reduce viral replication, control viral load, delay the emergence of drug resistance, improve immune function, and slow down the progression of HIV infection and AIDS.